Excision is a startup based in the United States, 5 tracked investors.
Excision is a company founded in 2020 headquartered in the United States. Brouky records 5 investors associated with the company.
A company categorized under Synthetic Biology + Therapeutics; focuses on developing therapeutics using synthetic biology approaches.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.